DENNER ALEXANDER J
Insider CIK 1361754 · APRI 10% owner · INVA 10% owner · MDCO Director · IRWD Director, 10% owner · RGLS 10% owner · ITRM 10% owner · BIVV Director · SRSA 10% owner · ENZN Director · BIIB Director · AMLN Director · VVUS Director · ARIA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2026-09-15 | 2026-09-17 | 3,694 | — | $0 | 327,549 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2026-09-15 | 2026-09-17 | 3,694 | — | $0 | 327,549 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2026-06-16 | 2026-06-17 | 63,481 | — | $0 | 323,855 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2026-06-15 | 2026-06-17 | 4,065 | — | $0 | 260,374 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2026-03-17 | 2026-03-17 | 6,725,000 | $3.05 | $20.51M | 9,194,435 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2026-03-17 | 2026-03-17 | 5,800 | $3.31 | $19.2K | 9,188,635 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2026-03-13 | 2026-03-17 | 4,451 | — | $0 | 256,309 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-12-15 | 2025-12-17 | 4,178 | — | $0 | 251,858 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-09-15 | 2025-09-17 | 11,718 | — | $0 | 247,680 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-06-13 | 2025-06-17 | 24,193 | — | $0 | 235,962 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-06-10 | 2025-06-12 | 45,000 | — | $0 | 211,769 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-04-02 | 2025-04-04 | 10,416 | — | $0 | 166,769 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2025-03-06 | 2025-03-06 | 1,196,746 | $17.52 | $20.97M | 5,658,705 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2025-03-05 | 2025-03-06 | 270,374 | $17.63 | $4.77M | 6,855,451 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2025-03-04 | 2025-03-06 | 151,175 | $17.63 | $2.67M | 7,125,825 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-12-16 | 2024-12-18 | 4,249 | — | $0 | 156,353 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-09-16 | 2024-09-18 | 3,282 | — | $0 | 152,104 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-06-18 | 2024-06-21 | 24,311 | — | $0 | 148,822 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-06-15 | 2024-06-18 | 2,572 | — | $0 | 124,511 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-03-15 | 2024-03-19 | 1,662 | — | $0 | 121,939 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-12-15 | 2023-12-19 | 1,347 | — | $0 | 120,277 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-09-15 | 2023-09-19 | 1,798 | — | $0 | 118,930 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-06-20 | 2023-06-22 | 22,350 | — | $0 | 117,132 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-06-15 | 2023-06-20 | 1,359 | — | $0 | 94,782 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-06-15 | 2023-06-20 | 62,000 | $13.13 | $814.1K | 7,277,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-06-06 | 2023-06-07 | 8,000 | $13.05 | $104.4K | 7,215,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-06-05 | 2023-06-07 | 7,000 | $13.04 | $91.3K | 7,207,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-30 | 2023-05-30 | 120,000 | $13.01 | $1.56M | 7,200,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-26 | 2023-05-30 | 30,000 | $13.12 | $393.6K | 7,080,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-25 | 2023-05-30 | 50,000 | $13.09 | $654.5K | 7,050,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-19 | 2023-05-19 | 36,000 | $13.48 | $485.3K | 7,000,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-18 | 2023-05-19 | 10,000 | $13.05 | $130.5K | 6,964,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-18 | 2023-05-19 | 10,000 | $13.05 | $130.5K | 6,964,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-17 | 2023-05-19 | 50,000 | $13.07 | $653.5K | 6,954,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-17 | 2023-05-19 | 50,000 | $13.07 | $653.5K | 6,954,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-11 | 2023-05-15 | 290,000 | $12.34 | $3.58M | 6,904,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-03-15 | 2023-03-17 | 1,438 | — | $0 | 93,423 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-12-15 | 2022-12-19 | 1,244 | — | $0 | 91,985 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-09-15 | 2022-09-19 | 1,374 | — | $0 | 90,741 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2022-06-15 | 2022-06-17 | 1,370 | — | $0 | 15,099 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-06-15 | 2022-06-17 | 1,222 | — | $0 | 89,367 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-06-01 | 2022-06-03 | 21,571 | — | $0 | 88,145 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-03-15 | 2022-03-17 | 1,152 | — | $0 | 66,574 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-12-15 | 2021-12-17 | 1,211 | — | $0 | 65,422 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-09-15 | 2021-09-17 | 1,137 | — | $0 | 64,211 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2021-07-01 | 2021-07-02 | 775 | — | $0 | 13,729 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-06-15 | 2021-06-16 | 1,229 | — | $0 | 63,074 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-06-02 | 2021-06-04 | 22,766 | — | $0 | 61,845 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-03-15 | 2021-03-17 | 1,235 | — | $0 | 39,079 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-10 | 2021-03-10 | 75,000 | $10.54 | $790.5K | 16,390,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-08 | 2021-03-10 | 150,000 | $10.30 | $1.54M | 16,315,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-05 | 2021-03-05 | 175,000 | $10.01 | $1.75M | 16,165,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-04 | 2021-03-05 | 250,000 | $10.00 | $2.50M | 15,990,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-03 | 2021-03-05 | 350,000 | $10.02 | $3.51M | 15,740,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-02 | 2021-03-02 | 500,000 | $9.56 | $4.78M | 15,390,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-01 | 2021-03-02 | 344,900 | $9.60 | $3.31M | 14,890,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-02-26 | 2021-03-02 | 505,100 | $9.20 | $4.65M | 14,545,100 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2021-02-12 | 2021-02-12 | 10,619,949 | $2.27 | $24.11M | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2021-02-11 | 2021-02-12 | 15,000,000 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2021-02-11 | 2021-02-12 | 10,000,000 | $2.59 | $25.90M | 10,619,949 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2021-02-11 | 2021-02-12 | 20,619,949 | — | $0 | 20,616,949 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2020-12-15 | 2020-12-17 | 661 | — | $0 | 37,844 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2020-11-09 | 2020-11-09 | 12,258 | — | $0 | 12,258 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2020-11-09 | 2020-11-09 | 24,925 | — | $0 | 37,183 | SEC↗ |
| SRSA Sarissa Capital Acquisitio | J Other deriv | 2020-10-30 | 2020-11-03 | 31,250 | — | $0 | 5,000,000 | SEC↗ |
| SRSA Sarissa Capital Acquisitio | P Buy deriv | 2020-10-23 | 2020-10-23 | 3,333,333 | $1.50 | $5.00M | 3,333,333 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2020-06-03 | 2020-06-05 | 890 | — | $0 | 12,954 | SEC↗ |
| MDCO MEDICINES CO /DE | D To issuer deriv | 2020-01-06 | 2020-01-06 | 13,410 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | D To issuer deriv | 2020-01-06 | 2020-01-06 | 27,230 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | D To issuer deriv | 2020-01-06 | 2020-01-06 | 9,700 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | D To issuer deriv | 2020-01-06 | 2020-01-06 | 8,577 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | D To issuer deriv | 2020-01-06 | 2020-01-06 | 9,141 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | D To issuer | 2020-01-06 | 2020-01-06 | 4,202,000 | — | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | D To issuer | 2020-01-06 | 2020-01-06 | 85,813 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2020-01-03 | 423,162 | — | $0 | 423,162 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2020-01-03 | 4,231,620 | — | $0 | 6,083,471 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-06-28 | 2019-06-28 | 50,000 | $33.00 | $1.65M | 4,202,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2019-06-19 | 2019-06-20 | 1,155 | — | $0 | 12,064 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2019-05-30 | 2019-06-03 | 13,410 | — | $0 | 13,410 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-05-30 | 2019-05-31 | 50,000 | $34.81 | $1.74M | 4,152,000 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2019-05-30 | 2019-06-03 | 3,663 | — | $0 | 14,092 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-05-29 | 2019-05-31 | 35,000 | $34.85 | $1.22M | 4,102,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-05-22 | 2019-05-22 | 139,000 | $33.13 | $4.61M | 4,067,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-05-21 | 2019-05-22 | 132,000 | $33.95 | $4.48M | 3,928,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-05-20 | 2019-05-22 | 160,000 | $34.50 | $5.52M | 3,796,000 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2019-05-02 | 2019-05-02 | 38,000 | $231.24 | $8.79M | 643,000 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2019-05-01 | 2019-05-02 | 30,000 | $229.46 | $6.88M | 605,000 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2019-04-30 | 2019-05-02 | 50,342 | $229.25 | $11.54M | 575,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-03-06 | 2019-03-08 | 248,100 | $24.91 | $6.18M | 3,636,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-03-05 | 2019-03-05 | 181,900 | $26.07 | $4.74M | 3,387,900 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-03-04 | 2019-03-05 | 325,000 | $25.45 | $8.27M | 3,206,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2019-03-01 | 2019-03-05 | 100,000 | $25.15 | $2.52M | 2,881,000 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2019-02-01 | 2019-02-01 | 7,000 | $328.45 | $2.30M | 524,658 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2019-01-31 | 2019-02-01 | 25,800 | $330.52 | $8.53M | 517,658 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2019-01-30 | 2019-02-01 | 30,000 | $324.86 | $9.75M | 491,858 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2018-12-20 | 2018-12-21 | 10,000 | $17.89 | $178.9K | 2,781,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy deriv | 2018-12-18 | 2018-12-18 | 0 | $20000000.00 | $0 | 0 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2018-12-18 | 2018-12-18 | 10,000 | $18.18 | $181.8K | 2,771,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2018-12-17 | 2018-12-18 | 20,000 | $17.91 | $358.2K | 2,761,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2018-12-14 | 2018-12-17 | 219,000 | $18.97 | $4.15M | 2,741,000 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2018-12-13 | 2018-12-17 | 600,000 | $20.73 | $12.44M | 2,522,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2018-06-12 | 2018-06-14 | 880 | — | $0 | 10,909 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2018-05-31 | 2018-06-04 | 9,141 | — | $0 | 9,141 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2018-05-31 | 2018-06-04 | 3,766 | — | $0 | 10,429 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2018-04-25 | 2018-04-27 | 48,000 | $269.91 | $12.96M | 461,858 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | J Other deriv | 2018-03-21 | 2018-03-23 | 653,409 | — | $0 | 0 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | J Other deriv | 2018-03-21 | 2018-03-23 | 653,409 | — | $0 | 653,409 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 26,818 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 5,455 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer | 2018-03-08 | 2018-03-08 | 1,165,000 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer | 2018-03-08 | 2018-03-08 | 5,001 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2018-01-31 | 2018-02-02 | 5,455 | — | $0 | 5,455 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2017-11-29 | 2017-11-30 | 10,000 | $319.84 | $3.20M | 413,858 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2017-11-29 | 2017-11-30 | 170,000 | $30.03 | $5.11M | 1,922,000 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2017-11-28 | 2017-11-30 | 20,000 | $316.12 | $6.32M | 403,858 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy deriv | 2017-08-31 | 2017-09-01 | 2,835 | — | $0 | 672,453 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2017-08-31 | 2017-08-31 | 933 | $316.56 | $295.4K | 383,858 | SEC↗ |
| BIVV Bioverativ Inc. | A Award | 2017-08-31 | 2017-08-31 | 932 | $56.69 | $52.8K | 1,165,000 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2017-08-31 | 2017-08-31 | 7,146 | $36.69 | $262.2K | 1,752,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy | 2017-08-31 | 2017-09-01 | 6,104 | $1.63 | $9.9K | 1,447,906 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2017-06-07 | 2017-06-09 | 1,055 | — | $0 | 10,029 | SEC↗ |
| BIVV Bioverativ Inc. | P Buy | 2017-05-30 | 2017-06-01 | 90,000 | $55.93 | $5.03M | 1,165,000 | SEC↗ |
| BIVV Bioverativ Inc. | P Buy | 2017-05-26 | 2017-05-26 | 450,000 | $57.21 | $25.74M | 1,075,000 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2017-05-25 | 2017-05-30 | 8,577 | — | $0 | 8,577 | SEC↗ |
| BIVV Bioverativ Inc. | P Buy | 2017-05-25 | 2017-05-26 | 130,000 | $54.98 | $7.15M | 625,000 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2017-05-25 | 2017-05-30 | 3,237 | — | $0 | 6,663 | SEC↗ |
| BIVV Bioverativ Inc. | P Buy | 2017-05-24 | 2017-05-26 | 340,000 | $54.16 | $18.41M | 495,000 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2017-04-27 | 2017-05-01 | 58,858 | $278.48 | $16.39M | 383,858 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2017-04-27 | 2017-05-01 | 15,000 | $278.58 | $4.18M | 325,000 | SEC↗ |
| BIVV Bioverativ Inc. | A Award | 2017-04-17 | 2017-04-17 | 1,056 | $56.83 | $60.0K | 5,001 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 75,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 3,459,280 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 5,340,720 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer | 2017-02-16 | 2017-02-16 | 53,173 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer | 2017-02-16 | 2017-02-16 | 7,798,665 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer | 2017-02-16 | 2017-02-16 | 5,051,335 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 26,770 | — | $0 | 26,770 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-03-27 | 26,818 | — | $0 | 26,818 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2017-01-31 | 2017-02-02 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2017-01-31 | 2017-02-02 | 12,500 | — | $0 | 53,173 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2017-01-31 | 2017-02-02 | 5,508 | — | $0 | 40,673 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2016-06-08 | 2016-06-09 | 1,060 | — | $0 | 8,950 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2016-05-26 | 2016-05-31 | 9,700 | — | $0 | 9,700 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2016-05-26 | 2016-05-31 | 3,426 | — | $0 | 3,426 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy deriv | 2016-03-03 | 2016-03-07 | 3,323,864 | — | $0 | 6,724,525 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy | 2016-03-03 | 2016-03-07 | 6,647,728 | $0.88 | $5.85M | 14,479,053 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2016-02-02 | 2016-02-04 | 27,230 | — | $0 | 27,230 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2016-02-01 | 2016-02-03 | 12,500 | — | $0 | 35,165 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy deriv | 2016-01-12 | 2016-01-14 | 653,409 | — | $0 | 3,400,661 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy | 2016-01-12 | 2016-01-14 | 1,306,819 | $0.88 | $1.15M | 7,831,324 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2015-10-30 | 2015-11-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2015-10-23 | 2015-10-26 | 100,000 | $276.77 | $27.68M | 310,000 | SEC↗ |
| BIIB BIOGEN INC. | P Buy | 2015-10-22 | 2015-10-26 | 210,000 | $277.80 | $58.34M | 210,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2015-06-10 | 2015-06-11 | 695 | — | $0 | 7,890 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2015-05-27 | 2015-05-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2015-01-31 | 2015-02-04 | 25,000 | $6.45 | $161.3K | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2015-01-31 | 2015-02-04 | 22,665 | — | $0 | 22,665 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | P Buy deriv | 2014-08-18 | 2014-08-19 | 5,340,720 | $5026953.00 | $26847.55B | 5,340,720 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | P Buy deriv | 2014-08-18 | 2014-08-19 | 3,459,280 | $3256047.00 | $11263.58B | 3,459,280 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | P Buy | 2014-08-15 | 2014-08-19 | 615,466 | $5.83 | $3.59M | 7,798,665 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | P Buy | 2014-08-15 | 2014-08-19 | 234,534 | $5.83 | $1.37M | 5,051,335 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2014-06-12 | 2014-06-16 | 870 | — | $0 | 7,195 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2014-02-20 | 2014-02-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VVUS VIVUS INC | P Buy | 2013-11-11 | 2013-11-12 | 149,776 | $8.78 | $1.32M | 2,573,943 | SEC↗ |
| VVUS VIVUS INC | P Buy | 2013-11-08 | 2013-11-12 | 417,068 | $8.52 | $3.55M | 2,424,167 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2013-08-14 | 2013-08-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-06-14 | 2013-06-17 | 2,900 | $212.00 | $614.8K | 6,325 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2013-06-12 | 2013-06-13 | 1,305 | — | $0 | 9,225 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-05-29 | 2013-05-31 | 3,000 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-05-29 | 2013-05-31 | 3,000 | $53.43 | $160.3K | 7,920 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-05-28 | 2013-05-29 | 2,975 | — | $0 | 3,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-05-28 | 2013-05-29 | 35,000 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 300 | $237.38 | $71.2K | 7,595 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-05-28 | 2013-05-29 | 2,975 | $53.43 | $159.0K | 7,895 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 906 | $242.40 | $219.6K | 4,920 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 12,094 | $241.92 | $2.93M | 5,826 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 7,500 | $240.75 | $1.81M | 17,920 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 1,500 | $238.87 | $358.3K | 6,095 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 900 | $239.04 | $215.1K | 36,720 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 2,300 | $237.73 | $546.8K | 37,620 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-05-28 | 2013-05-29 | 35,000 | $53.43 | $1.87M | 39,920 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 11,300 | $239.95 | $2.71M | 25,420 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 1,175 | $239.85 | $281.8K | 4,920 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award deriv | 2013-01-02 | 2013-01-04 | 40,258 | — | $0 | 40,258 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-12-27 | 2012-12-28 | 2,691 | $148.02 | $398.3K | 6,220 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-12-27 | 2012-12-28 | 1,300 | $149.05 | $193.8K | 4,920 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-12-26 | 2012-12-28 | 3,989 | $148.89 | $593.9K | 8,911 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 30,000 | $31.00 | $930.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 1,104 | $31.00 | $34.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 9,057 | $31.00 | $280.8K | 1,104 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award | 2012-07-02 | 2012-07-03 | 21,338 | — | $0 | 60,620 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2012-06-08 | 2012-06-11 | 2,020 | — | $0 | 12,900 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-05-15 | 2012-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-05-15 | 2012-05-17 | 3,000 | — | $0 | 10,161 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | M Exercise deriv | 2012-01-17 | 2012-01-19 | 4,889 | — | $0 | 1,104 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | M Exercise deriv | 2012-01-17 | 2012-01-19 | 1,104 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-01-17 | 2012-01-19 | 1,832 | $11.59 | $21.2K | 7,161 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | M Exercise | 2012-01-17 | 2012-01-19 | 4,889 | — | $0 | 7,889 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | M Exercise | 2012-01-17 | 2012-01-19 | 1,104 | — | $0 | 8,993 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award deriv | 2012-01-03 | 2012-01-05 | 21,988 | — | $0 | 21,988 | SEC↗ |